Asset Prioritization in Pharma Domain: How In-Licensing Led to the Selection of a High-Value Game-Changing Asset for a Pharma Client

A case study on how a mid-sized pharmaceutical company collaborated with DelveInsight to expand its asset portfolio in the Atrial Fibrillation space. DelveInsight conducted comprehensive asset prioritization, identifying the most promising Phase II therapeutic candidates for licensing…